Leo Groenewegen
Chief Executive Officer at NBAB, Nordic BioAnalysis AB
Leo Groenewegen active positions
| Companies | Position | Start | End |
|---|---|---|---|
NBAB, Nordic BioAnalysis AB
 NBAB, Nordic BioAnalysis AB BiotechnologyHealth Technology Part of Ilya Pharma AB, NBAB, Nordic BioAnalysis AB engages in bio analytical development, validation and analysis of medicines. The company is based in Södertälje, Sweden. The Swedish company was founded in 2010. The CEO is Leo Groenewegen. NBAB was acquired by Ilya Pharma AB on April 19, 2022. | Chief Executive Officer | 2022-08-31 | - |
Career history of Leo Groenewegen
Former positions of Leo Groenewegen
| Companies | Position | Start | End |
|---|---|---|---|
| NEXTCELL PHARMA AB | Director of Finance/CFO | - | - |
| Corporate Officer/Principal | - | 2019-08-31 |
Statistics
International
| Sweden | 3 |
Operational
| Director of Finance/CFO | 1 |
| Corporate Officer/Principal | 1 |
| Chief Executive Officer | 1 |
Sectoral
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| NEXTCELL PHARMA AB | Health Technology |
| Private companies | 1 |
|---|---|
NBAB, Nordic BioAnalysis AB
NBAB, Nordic BioAnalysis AB BiotechnologyHealth Technology Part of Ilya Pharma AB, NBAB, Nordic BioAnalysis AB engages in bio analytical development, validation and analysis of medicines. The company is based in Södertälje, Sweden. The Swedish company was founded in 2010. The CEO is Leo Groenewegen. NBAB was acquired by Ilya Pharma AB on April 19, 2022. | Health Technology |
- Stock Market
- Insiders
- Leo Groenewegen
- Experience
